Revealing new regulators of EGFR-P13K driven glioma proliferation and migration
Revealing new regulators of EGFR-P13K driven glioma proliferation and migration
批准号:
8450950
负责人:
Renee D Read
金额:
$24.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-15 至 2015-05-31
关键词:
1-Phosphatidylinositol 3-KinaseApoptosisAstrocytesBioinformaticsBiological AssayBiological ModelsBrainCandidate Disease GeneCell CommunicationCellsChromosome DeletionDrosophila genusEpidermal Growth Factor ReceptorGenesGeneticGenetic ScreeningGenetic TechniquesGenomeGlioblastomaGliomaGrowthHumanInstructionIntegral Membrane ProteinLaboratoriesMalignant NeoplasmsMammalian GeneticsModelingMolecularNeoplasm MetastasisNeoplasmsNervous system structureNeurogliaNeuronsOrthologous GeneOutputPathogenesisPathway interactionsPatternPhenotypePhosphotransferasesProliferatingPropertyProteinsRNA InterferenceRegulationRoleSignal PathwaySignal TransductionSystemTherapeuticTrainingTranslatingTumor Cell Invasionbasecell transformationcell typeflyfollow-uphuman diseaseinsightloss of functionmigrationmouse modelneoplasticnoveloverexpressionresponsetherapeutic targettumor
中文摘要
胶质母细胞瘤(GBM)是中枢神经系统最常见、最致命的恶性肿瘤。GBM
细胞迅速增殖并弥漫性浸润大脑,这些特性使这些肿瘤大部分
无法治愈为了有效地控制GBM,肿瘤细胞侵袭和增殖的机制必须
被新疗法所理解和靶向。EGFR-Ras和PI-3激酶的组成性激活
(PI 3 K)信号通路是人类GBM中的常见特征,并且足以引起胶质母细胞瘤样细胞凋亡。
小鼠模型中的表型。这些信号通路如何特异性地控制神经胶质的发病机制,
不清楚建立了一种新的果蝇模型,以了解EGFR和PI 3 K驱动的分子基础。
GBM。当使用遗传技术靶向神经胶质和神经胶质前体时,EGFR和PI 3 K的共激活
在果蝇中,神经胶质细胞会产生肿瘤性的、侵袭性的神经胶质细胞,产生可移植的肿瘤样生长。
模仿人类的疾病这种模式!已被用于识别神经胶质瘤形成的新调节因子
通过基因筛选和表型分析。在这些中鉴定的新基因的人类直系同源物
筛选评估了它们在人类GBM中的参与,因为它们代表了优秀的候选者
直接参与发病机制的基因我的研究结果揭示了非典型激酶,它们是
GBM细胞的增殖和存活,并且这些激酶中的一种足以转化GBM细胞,
永生化星形胶质细胞。我的研究结果表明,这些激酶的过度表达产生了一个前馈回路,
促进和维持GBM细胞转化,该环的破坏触发GBM细胞凋亡
细胞对这些激酶的研究旨在阐明它们在转化中的特定作用,
果蝇和哺乳动物系统中的EGFR-PI 3 K信号传导。
英文摘要
Glioblastoma (GBM) is the most common and deadly malignant tumor of the centrail nervous system. GBM
cells proliferate rapidly and diffusely infiltrate the brain, properties which render these tumors largely
incurable. To effectively control GBM, the mechanisms underlying tumor cell invasion and proliferation must
be understood and targeted with novei therapies. Constitutive activation of the EGFR-Ras and PI-3 kinase
(PI3K) signaling pathways is a common feature in human GBM and is sufficient to cause glioblastoma-like
phenotypes in mouse models. How these signaling pathways specifically control glial pathogenesis is
unclear. A novel Drosophila model was created to understand the molecular basis df EGFR and PI3K driven
GBM. When targeted to glia and glial precursors using genetic techniques, co-activation of EGFR and PI3K
in Drosophila gives rise to neoplastic, invasive glial cells that create transplantable tumor-like growths^
mimicking the human disease. This mode! has been used to identify new regulators of glial neoplasia
through genetic screens and phenotypic analyses. Human orthologs of novel genes identified in these
screens were assessed for their involvement in human GBM because they represent excellent candidates
for genes directly involved in the pathogenesis. My results reveal atypical kinases that are necessary forthe
proliferation and survival of GBM cells, and that one of these kinases sufficient for transformation of
irnmortalized astrocytes. My results suggest that overexpression of these kinases creates a feedforward loop
that promotes and maintains GBM cell transformation, and disruption of this loop triggers apoptosis of GBM
cells. Proposed iStudies of these kinases are aimed,at elucidating their specific roles in transformation and
EGFR-PI3K signaling in both Drosophila and mammalian systems.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Human Organoid Models for Pediatric High-Grade Gliomas
-
批准号:10727450
-
项目类别:
-
资助金额:$43.04万
-
财政年份:2023
-
负责人:Renee D Read
-
依托单位:
Verteporfin as a YAP/TAZ inhibitor for treatment of glioblastoma
-
批准号:10737348
-
项目类别:
-
资助金额:$57.75万
-
财政年份:2023
-
负责人:Renee D Read
-
依托单位:
MET kinase fusions in pediatric glioblastoma
-
批准号:10690229
-
项目类别:
-
资助金额:$2.19万
-
财政年份:2022
-
负责人:Renee D Read
-
依托单位:
MET kinase fusions in pediatric glioblastoma
-
批准号:10373782
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2021
-
负责人:Renee D Read
-
依托单位:
MET kinase fusions in pediatric glioblastoma
-
批准号:10756382
-
项目类别:
-
资助金额:$3.76万
-
财政年份:2021
-
负责人:Renee D Read
-
依托单位:
MET kinase fusions in pediatric glioblastoma
-
批准号:10532158
-
项目类别:
-
资助金额:$19.56万
-
财政年份:2021
-
负责人:Renee D Read
-
依托单位:
Mechanisms of RIOK2 function in glioblastoma
-
批准号:10232051
-
项目类别:
-
资助金额:$33.77万
-
财政年份:2017
-
负责人:Renee D Read
-
依托单位:
Revealing new regulators of EGFR-P13K driven glioma proliferation and migration
-
批准号:8668168
-
项目类别:
-
资助金额:$24.65万
-
财政年份:2012
-
负责人:Renee D Read
-
依托单位:
Revealing new regulators of EGFR-P13K driven glioma proliferation and migration
-
批准号:8504550
-
项目类别:
-
资助金额:$24.03万
-
财政年份:2012
-
负责人:Renee D Read
-
依托单位:
Revealing new regulators of EGFR-P13K driven glioma proliferation and migration
-
批准号:7707429
-
项目类别:
-
资助金额:$8.35万
-
财政年份:2009
-
负责人:Renee D Read
-
依托单位:
Wnt signaling via the Drl axon guidance receptor
-
批准号:7276031
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2005
-
负责人:Renee D Read
-
依托单位:
Wnt signaling via the Drl axon guidance receptor
-
批准号:7003068
-
项目类别:
-
资助金额:$4.4万
-
财政年份:2005
-
负责人:Renee D Read
-
依托单位:
Wnt signaling via the Drl axon guidance receptor
-
批准号:7217560
-
项目类别:
-
资助金额:$4.88万
-
财政年份:2005
-
负责人:Renee D Read
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: